Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle
Daxor Corporation Common Stock | FinOracle

Daxor Corporation Common Stock

Symbol: (NASDAQ:DXR)

Daxor Corporation Common Stock is a medical technology company. It develops and sells medical devices for precision blood volume analysis. The company provides personalized patient management solutions to healthcare providers. Its products include the BVA-100, a blood volume analyzer that is used in various medical specialties to aid in the diagnosis and treatment of patients.

Latest News

Welcome Back!

Login to your account below

Create New Account!

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.

Home
Trends
Premium
Favorite
Account
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?